<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03620006</url>
  </required_header>
  <id_info>
    <org_study_id>SAPE</org_study_id>
    <nct_id>NCT03620006</nct_id>
  </id_info>
  <brief_title>Subclavian Artery Plug Embolization (SAPE)</brief_title>
  <acronym>SAPE</acronym>
  <official_title>Endovascular Occlusion by Plug of the Prevertebral Subclavian Artery Preparatory to the Surgical or Endovascular Aortic Procedures (SAPE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, no-profit, ambispective study: a retrospective arm will include the
      cases treated between August 2009 and March 2018, and a prospective arm, investigating
      patients treated from March 2018 until December 2018. Target study population size is 150
      patients between two groups analyzed.

      Endovascular occlusion of the prevertebral subclavian artery was first used in the Vascular
      Surgery Department at San Raffaele Hospital in August 2009. During the initial experience
      (2009-2014) this technique was used with low frequency. Since 2015, the volume of cases
      receiving this treatment, has increased and the investigators expect to reach the study
      population target, by the end of 2018.

      The objective of this study is describe the casuistry of endovascular occlusion of the
      subclavian artery by means of the Amplatzer Vascular plug in the Vascular Surgery Department
      at San Raffaele Hospital, and to evaluate the efficacy of such procedure.

      Moreover, the investigators will evaluate the patency and success rate of the
      carotid-subclavian bypasses performed at the same time of the analyzed procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Technical success rate</measure>
    <time_frame>within 30-day</time_frame>
    <description>Technical success rate defined as complete occlusion of the left subclavian artery at postoperative CT scan</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major adverse event rate</measure>
    <time_frame>within 30-day</time_frame>
    <description>Any stroke or mortality related to the surgical procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Access site complications requiring secondary adjunctive procedures</measure>
    <time_frame>within 30-day</time_frame>
    <description>Any access site complication requiring open or endovascular adjuctive procedures (ie: surgical embolectomy, echo-guided pseudoaneurysm manual compression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Supra-aortic vessels patency rate</measure>
    <time_frame>within 5-years</time_frame>
    <description>Patency of the carotid and subaclavian artery at follow-up</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Subclavian Artery Plug Embolization</condition>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients aged ≥ 18 years, candidates for endovascular treatment of subclavian artery
        occlusion with Amplatzer Vascular Plug
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients aged ≥ 18 years,

          -  patients candidates for endovascular treatment of subclavian artery occlusion with
             Amplatzer Vascular Plug

        Exclusion Criteria:

        • none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luca Bertoglio</last_name>
    <phone>+39022643</phone>
    <phone_ext>7381</phone_ext>
    <email>bertoglio.luca@hsr.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Bertoglio, MD</last_name>
      <email>bertoglio.luca@hsr.it</email>
    </contact>
    <contact_backup>
      <last_name>Tommaso Cambiaghi, MD</last_name>
      <email>tommaso.cambiaghi@yahoo.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 21, 2018</study_first_submitted>
  <study_first_submitted_qc>August 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Bertoglio Luca</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

